Brian joined us in 2000. Prior to joining us, he worked in Institutional Sales at Adams Harkness & Canaccord Genuity. Brian has been a Managing Director in Equity Capital Markets since 2008, where he has executed transactions across Growth Sectors. He started his career at The Boston Company. Brian holds a BA in English Language and Literature from The College of the Holy Cross.
Selected Transactions
-
US$85m
Delcath Systems
Sole Placement Agent
-
US$1.2b
Environmental Impact Acquisition Corp.
Financial Advisor on Merger with GreenLight Biosciences
-
US$50m
Cardiol Therapeutics, Inc.
Lead Left Bookrunner (Follow-On Offering)
-
US$69m
Exagen Inc.
Bookrunner (Follow-on)
-
US$60m
RADA Electronic Industries LTD.
Joint Bookrunner (Follow-on)
-
US$175m
Travere Therapeutics Inc.
Lead Manager (Follow-on)
-
US$69m
Kaledio
Lead Manager (Follow-On)
-
US$173m
Rhythm Pharmaceuticals, Inc.
Lead Manager (Follow-On)
-
US$138m
Adicet Bio, Inc.
Co-Manager (CMPO)
-
US$50m
VSE Corporation
Lead Manager (Follow-on)
-
US$288m
Silvergate Capital Corporation
Joint Bookrunner (Follow-on)
-
US$400m
Lithium Americas
Lead Bookrunner (Follow-on)
-
US$69m
Motorsport Games
Left Bookrunner (IPO)
-
N/a
XL Fleet
Financial Advisor (Private Placement)
-
Barkbox
Financial advisor on Merger with Northern Star Acquisition Corp.
